Some women who use drugs like Ozempic have reported unexpected pregnancies. What’s going on?
Academic rigor, journalistic flair
Articles on Weight loss drugs
Displaying all articles
In Australia, Ozempic is only approved to treat diabetes but doctors are prescribing it ‘off label’ for weight loss. Compounding pharmacies have also been making their own versions to meet demand.
Ozempic generated A$21 billion of sales in 2023 alone. So how was it developed? And how are its new competitors, Mounjaro and Zepbound, different?
Early on we heard a lot about the potential benefits of drugs like Ozempic. Now we’re hearing more about the risks. But what does the latest evidence say?
Adopting healthy behaviors and thought patterns around food and nutrition takes time and intentional effort. But it will lead to more lasting change and positive outcomes than quick-fix dieting will.
The first-ever imaging and recording of a brainstem structure critical for feeling full could help reveal exactly how weight loss drugs like Ozempic work, and how to make them more effective.
Weight loss and diabetes drugs target regulatory pathways involved in metabolism that the microbes in your gut and certain molecules from food already play a key role in regulating.
Medications can play an important role in weight management, but not at the expense of overall nutrition. And healthy lifestyle habits are also key.
The messaging around Ozempic being a miracle cure is not only a lie, it has kicked up a new level of fatphobia.
Ongoing shortages of the drug have been reported in the UK, Australi and Ireland.
As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?
Obesity is said to cost the NHS an estimated £6 billion a year.
Anti-obesity medications are becoming the go-to treatment for weight loss. But drugs alone may not provide the same benefits as lifestyle choices like exercise and a healthy diet.
Top contributors
-
Assistant Professor, Critical Disability Studies, Carleton University
-
Lecturer, Southern Cross University
-
Professor of Community Health and Wellbeing, The University of Queensland
-
Lecturer Pharmacy Practice, University of Sydney
-
Associate Lecturer, Sydney Pharmacy School, University of Sydney
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Professor of Exercise Science and Interim Dean of the School of Health Sciences, College of Charleston
-
Associate Professor of Metabolic Medicine, University of Surrey
-
Emeritus Professor of Reproductive and Periconceptual Medicine, The Robinson Research Institute, University of Adelaide
-
Karin Hammarberg is a Friend of The Conversation.
Senior Research Fellow, Global and Women's Health, School of Public Health & Preventive Medicine, Monash University
-
Associate Professor in Pharmacy Practice, University of Bradford
-
Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Professor of Health Service Operations, University of Bradford
-
Practice Pharmacist/Honorary Senior Research Fellow, University of Bradford
-
Professor, Institute of Feminist and Gender Studies | School of Political Studies, L’Université d’Ottawa/University of Ottawa
-
Assistant Clinical Professor in Nutrition and Dietetics, Mississippi State University
